MedPath

clinical study of cervical curvature rehabilitation device combined with joint loosening manipulation to correct abnormal cervical curvature

Phase 1
Conditions
Abnormal cervical curvature
Registration Number
ITMCTR2000003649
Lead Sponsor
onghua Hospital, Shanghai University of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Informed consent and sign informed consent form;
2. According to the diagnostic criteria of cervical spondylosis and abnormal cervical curvature;
3. Male or female aged 15-40 years;
4. Voluntarily accept the required joint loosening manipulation combined with cervical curvature rehabilitation appliance exercise;
5. No other treatment was given during the study period.

Exclusion Criteria

1. The patients who refused the treatment plan randomly divided into two groups, and those who had participated in or were participating in other clinical researches in the past three months;
2. The muscle strength decreased significantly in a short period of time, and the muscle strength was lower than grade III. The patients who had been treated with regular non-surgical therapy for six months had no effect;
3. Patients with severe cervical pain, cervical spinal cord compression, cauda equina syndrome and unstable lower limb walking were found;
4. The patients with serious cervical deformity, fracture, osteopathy, tuberculosis, tumor and other complicated diseases by imaging examination, and those with severe cervical trauma history and cervical spondylosis surgery treatment history;
5. Patients with severe primary diseases such as liver, kidney, hematopoietic system, endocrine system, cardio cerebrovascular system, nervous system, tuberculosis, vertebral malformation, malignant tumor and psychosis; patients suspected of sedative hypnotics, opioid analgesics and alcohol abuse; patients with skin diseases and infectious diseases; patients with severe primary diseases such as liver, kidney, hematopoiesis, endocrine system, cardiovascular and cerebrovascular diseases, and psychiatric patients;
6. Pregnant woman, or ready for pregnancy or lactation;
7. Patients who are not suitable or unable to use this treatment method for other reasons;
8. Patients with mental disorders, language disorders, motor dysfunction, mental illness.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
DI score;VAS score;X-ray;
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath